ctrl K

AI Score

Unlock

Fulcrum Therapeutics Inc. (FULC)

AI Score

Unlock

3.21

-0.38 (-10.58%)

At close: Mar 03, 2025, 3:59 PM

3.16

-1.56%

Pre-market: Mar 04, 2025, 08:26 AM EST

Fulcrum Therapeutics Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Revenue	2.81M	6.34M	19.16M	8.82M	n/a	n/a	n/a
Cost of Revenue	n/a	2.41M	2.52M	2.38M	2.05M	1.34M	715K
Gross Profit	2.81M	3.93M	16.65M	6.44M	-2.05M	-1.34M	-715K
Operating Income	-110.66M	-112.56M	-81.05M	-71.61M	-84.22M	-33.5M	-22.99M
Interest Income	n/a	n/a	207K	792K	1.51M	n/a	n/a
Pretax Income	-97.33M	-109.87M	-80.85M	-70.82M	-82.68M	-32.59M	-22.96M
Net Income	-97.33M	-105.62M	-78.33M	-68.44M	-79.11M	-32.59M	-22.96M
Selling & General & Admin	41.67M	41.69M	30.52M	21.39M	13.14M	8.31M	4.5M
Research & Development	71.8M	76.78M	69.7M	59.04M	71.07M	25.18M	18.49M
Other Expenses	n/a	2.69M	207K	792K	29K	392K	28K
Operating Expenses	113.47M	118.48M	100.22M	80.43M	84.22M	33.5M	22.99M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	113.47M	118.48M	100.22M	80.43M	84.22M	33.5M	22.99M
Income Tax	n/a	-4.25M	-2.52M	-2.38M	-3.56M	910K	-1K
Shares Outstanding (Basic)	61.31M	44.99M	35.36M	25.35M	11.05M	16.94M	10.95M
Shares Outstanding (Diluted)	61.31M	44.99M	35.36M	25.35M	11.05M	16.94M	10.95M
EPS (Basic)	-1.59	-2.35	-2.22	-2.7	-7.16	-1.92	-2.1
EPS (Diluted)	-1.59	-2.35	-2.22	-2.7	-7.16	-1.92	-2.1
EBITDA	-108.49M	-109.72M	-78.54M	-69.23M	-82.16M	-32.15M	-22.28M
Depreciation & Amortization	2.17M	2.41M	2.52M	2.38M	2.05M	1.34M	715K